D L Scott1, G H Kingsley. Show Affiliations » 1. Department of Rheumatology, Kings College London School of Medicine, Weston Education Centre, Kings College, London.
Abstract
Entities: Disease
Mesh: See more » AdalimumabAdultAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/physiopathologyEtanerceptFemaleHumansImmunoglobulin G/adverse effectsImmunoglobulin G/therapeutic useInfliximabPractice Guidelines as TopicReceptors, Tumor Necrosis Factor/therapeutic useRecombinant Fusion ProteinsTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorRecombinant Fusion ProteinsTumor Necrosis Factor-alphaInfliximabAdalimumabEtanercept
Year: 2006 PMID: 16914706 DOI: 10.1056/NEJMct055183
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245